These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32919215)

  • 1. Identification of immune-related biomarkers in adrenocortical carcinoma: Immune-related biomarkers for ACC.
    Peng Y; Song Y; Ding J; Li N; Zhang Z; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106930. PubMed ID: 32919215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
    Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
    Surgery; 2022 Jan; 171(1):111-118. PubMed ID: 34261605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z; Cheng H; Zhang Y; Zhou Y
    Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
    Ma C; Xiong J; Su H; Li H
    Int J Med Sci; 2021; 18(13):3026-3038. PubMed ID: 34220331
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
    Luo L; Zhou H; Su H
    BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways.
    Veronez LC; das Chagas PF; Corrêa CAP; Baroni M; da Silva KR; Nagano LF; Borges KS; Queiroz RGP; Tone LG; Scrideli CA
    J Cell Biochem; 2021 Dec; 122(12):1925-1935. PubMed ID: 34581457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics.
    Subramanian C; Cohen MS
    Surgery; 2022 Jan; 171(1):119-129. PubMed ID: 34353633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
    Tian X; Xu W; Wang Y; Anwaier A; Wang H; Wan F; Zhu Y; Cao D; Shi G; Zhu Y; Qu Y; Zhang H; Ye D
    Oncoimmunology; 2020 Jun; 9(1):1784529. PubMed ID: 32923148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis Biomarkers for Predicting Prognosis and Immunotherapy Efficacy in Adrenocortical Carcinoma.
    Shen C; Wang Y
    Arch Med Res; 2023 Jan; 54(1):45-55. PubMed ID: 36528469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
    Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
    Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma.
    Luo Y; Chen Q; Lin J
    Math Biosci Eng; 2022 May; 19(7):7055-7075. PubMed ID: 35730296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
    Zeng H; Huang Y; Chen L; Li H; Ma X
    Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.